Cargando…

Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19

Detalles Bibliográficos
Autores principales:	Frise, Matthew C., Gates, Rebecca E.V., Curry, Nicola S., Danbury, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738232/ https://www.ncbi.nlm.nih.gov/pubmed/33336140 http://dx.doi.org/10.1055/s-0040-1721501

Ejemplares similares

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial
por: Treschan, Tanja A, et al.
Publicado: (2014)

Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis
por: Kim, Se-Chan, et al.
Publicado: (2015)

In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia
por: Nygaard, Søren, et al.
Publicado: (2023)

A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †
por: Bachler, Mirjam, et al.
Publicado: (2020)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

Conflict before the courtroom: challenging cognitive biases in critical decision-making
por: Johal, Harleen Kaur, et al.
Publicado: (2021)

Percutaneous dilatation tracheostomy in critically ill patients with documented coagulopathy
por: Kakar, P, et al.
Publicado: (2008)

Argatroban for an alternative anticoagulant in HIT during ECMO
por: Rougé, Alain, et al.
Publicado: (2017)

Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis
por: Yokota, Yuya, et al.
Publicado: (2019)

Severe Trauma-Induced Coagulopathy: Molecular Mechanisms Underlying Critical Illness
por: Zanza, Christian, et al.
Publicado: (2023)

Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
por: Agarwal, Shvetank, et al.
Publicado: (2012)

Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs
por: Lopez, Mercedes, et al.
Publicado: (2012)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

Argatroban Treatment and Decreased Fibrinogen in a Septic Patient
por: Ajmeri, Aman N, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021)

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill
por: Dechamps, Mélanie, et al.
Publicado: (2023)

Cefoperazone-induced Coagulopathy in Critically Ill Patients Admitted to Intensive Care Unit
por: Gudivada, Kiran Kumar, et al.
Publicado: (2023)

COVID-19-associated coagulopathy and acute kidney injury in critically ill patients
por: da Silva, Bruno Caldin, et al.
Publicado: (2023)

Successful Management of Heparin-Induced Thrombocytopenia Using Argatroban in a Very Old Woman: A Case Report
por: Putot, A., et al.
Publicado: (2013)

Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry – a prospectively controlled randomized double-blind clinical trial
por: Beiderlinden, Martin, et al.
Publicado: (2018)

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
por: Aliter, Kholoud F., et al.
Publicado: (2020)

Use of Argatroban in Donor Lung Procurement: A Case Report
por: Sharif, Limi, et al.
Publicado: (2021)

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
por: Colarossi, Giorgia, et al.
Publicado: (2021)

Safety of ultrasound-guided central venous access in critically ill patients with uncorrected coagulopathy
por: Reusz, G, et al.
Publicado: (2013)

Sepsis-Associated Coagulopathy Predicts Hospital Mortality in Critically Ill Patients With Postoperative Sepsis
por: Ren, Chao, et al.
Publicado: (2022)

Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
por: Huang, Jia-Jia, et al.
Publicado: (2023)

Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report
por: Ma, Hongrui, et al.
Publicado: (2023)

COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients
por: Martín-Rojas, Reyes María, et al.
Publicado: (2020)

Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Argatroban for anticoagulation of a blood salvage system - an ex-vivo study
por: Beiderlinden, Martin, et al.
Publicado: (2016)

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
por: McGlynn, Fergal, et al.
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

COVID-19-RELATED COAGULOPATHY IN CRITICALLY ILL PATIENTS: EXPERIENCE FROM AN ACADEMIC MEDICAL CENTER
por: THAYYIL JAYAKRISHNAN, THEJUS, et al.
Publicado: (2021)

Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
por: Wang, Chengli, et al.
Publicado: (2023)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
por: Lv, Bin, et al.
Publicado: (2022)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rn1f3illq6f1iftednes7t7utv